HomeSLS • NASDAQ
add
Sellas Life Sciences Group Inc
Previous close
$1.60
Day range
$1.58 - $1.68
Year range
$0.77 - $1.85
Market cap
162.64M USD
Avg Volume
1.96M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.06M | -37.14% |
Net income | -5.81M | 39.23% |
Net profit margin | — | — |
Earnings per share | -0.07 | 66.67% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.40M | 54.21% |
Total assets | 34.96M | 43.06% |
Total liabilities | 7.20M | -51.21% |
Total equity | 27.76M | — |
Shares outstanding | 99.78M | — |
Price to book | 5.16 | — |
Return on assets | -55.74% | — |
Return on capital | -77.54% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.81M | 39.23% |
Cash from operations | -9.07M | 15.71% |
Cash from investing | — | — |
Cash from financing | 23.58M | -11.50% |
Net change in cash | 14.51M | -8.65% |
Free cash flow | -7.56M | -3.10% |
About
Founded
2006
Website
Employees
15
